Deuterated 1-piperazino-3-phenyl-indanes for treatment of schizophrenia
AssigneeH. Lundbeck A/S
InventorsMorten Jorgensen, Peter Hongaard Andersen, Klaus Gjervig Jensen, Mette Graulund Hvenegaard, Lassina Badolo, Mikkel Fog Jacobsen
Life of this patent
Estimating the term…
Abstract
The present invention relates to deuterated 1-piperazino-3-phenyl-indanes and salts thereof with activity at dopamine receptors D1 and D2 as well as the 5HT2 receptors in the central nervous system, to medicaments comprising such compounds as active ingredients, to the use of such compounds in the treatment of diseases in the central nervous system, and to methods of treatment comprising administration of such compounds.
Claims30
A deuterium enriched compound of formula Y:
- wherein,
- R1-R10 are independently hydrogen or deuterium, wherein at least two of R1-R10 are deuterium, or a pharmaceutically acceptable acid addition salt thereof.
A pharmaceutical composition comprising deuterium enriched compounds of formula Y, wherein each compound of formula Y independently has the following structure:
- wherein,
- R1-R10 are independently hydrogen or deuterium, wherein at least two of R1-R10 are deuterium, or a pharmaceutically acceptable acid addition salt thereof, and one or more pharmaceutically acceptable carriers, diluents, or excipients.
A composition comprising deuterium enriched compounds of formula Y, wherein each compound of formula Y independently has the following structure:
- wherein,
- R1-R10 are independently hydrogen or deuterium, wherein at least two of R1-R10 are deuterium, or a pharmaceutically acceptable acid addition salt thereof.
Dependencies are inferred from the claim text.